The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

Research output: Contribution to journal › Article › Academic › peer-review

68 Citations (Scopus)

46 Downloads (Pure)

Research programs

@article{0b3d20aef8404aeab06f0897b4456f7f,

title = "The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research",

author = "Eline Ruigrok and \{van Weerden\}, Wytske and Julie Nonnekens and Marion Jong",

year = "2019",

doi = "10.3390/pharmaceutics11110560",

language = "Undefined/Unknown",

volume = "11",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "11",

}

TY - JOUR

T1 - The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

AU - Ruigrok, Eline

AU - van Weerden, Wytske

AU - Nonnekens, Julie

AU - Jong, Marion

PY - 2019

Y1 - 2019

U2 - 10.3390/pharmaceutics11110560

DO - 10.3390/pharmaceutics11110560

M3 - Article

C2 - 31671763

SN - 1999-4923

VL - 11

JO - Pharmaceutics

JF - Pharmaceutics

IS - 11

M1 - 560

ER -